Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Shunde HZ-Technology is a specialized medical technology company headquartered in Foshan, China, focusing on the field of in vitro diagnostics (IVD). The company is dedicated to the research, development, and large-scale production of automated Chemiluminescence Immunoassay (CLIA) systems and their corresponding reagent kits. Their product line includes high-throughput analyzers designed for clinical laboratories, as well as a comprehensive menu of assays for cardiac markers, inflammatory indicators, and hormonal balance. By leveraging advanced magnetic microbead and chemiluminescence technologies, HZ-Technology provides rapid and precise diagnostic results to support clinical decision-making. The company maintains rigorous quality standards, including ISO 13485 certification, to ensure the reliability of its diagnostic solutions in the global healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Shunde HZ-Technology.